Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

179 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Genomic Amplifications and Distal 6q Loss: Novel Markers for Poor Survival in High-risk Neuroblastoma Patients.
Depuydt P, Boeva V, Hocking TD, Cannoodt R, Ambros IM, Ambros PF, Asgharzadeh S, Attiyeh EF, Combaret V, Defferrari R, Fischer M, Hero B, Hogarty MD, Irwin MS, Koster J, Kreissman S, Ladenstein R, Lapouble E, Laureys G, London WB, Mazzocco K, Nakagawara A, Noguera R, Ohira M, Park JR, Pötschger U, Theissen J, Tonini GP, Valteau-Couanet D, Varesio L, Versteeg R, Speleman F, Maris JM, Schleiermacher G, De Preter K. Depuydt P, et al. Among authors: noguera r. J Natl Cancer Inst. 2018 Oct 1;110(10):1084-1093. doi: 10.1093/jnci/djy022. J Natl Cancer Inst. 2018. PMID: 29514301 Free PMC article.
Quality assessment of genetic markers used for therapy stratification.
Ambros IM, Benard J, Boavida M, Bown N, Caron H, Combaret V, Couturier J, Darnfors C, Delattre O, Freeman-Edward J, Gambini C, Gross N, Hattinger CM, Luegmayr A, Lunec J, Martinsson T, Mazzocco K, Navarro S, Noguera R, O'Neill S, Potschger U, Rumpler S, Speleman F, Tonini GP, Valent A, Van Roy N, Amann G, De Bernardi B, Kogner P, Ladenstein R, Michon J, Pearson AD, Ambros PF. Ambros IM, et al. Among authors: noguera r. J Clin Oncol. 2003 Jun 1;21(11):2077-84. doi: 10.1200/JCO.2003.03.025. J Clin Oncol. 2003. PMID: 12775732
[Neuroblastoma].
Castel V, Cañete A, Noguera R, Navarro S, Oltra S; Grupo Español de Neuroblastoma (SEOP). Castel V, et al. Among authors: noguera r. Clin Transl Oncol. 2005 Apr;7(3):133-45. doi: 10.1007/BF02708748. Clin Transl Oncol. 2005. PMID: 15899223 Review. Spanish. No abstract available.
Circulating MYCN DNA predicts MYCN-amplification in neuroblastoma.
Combaret V, Bergeron C, Noguera R, Iacono I, Puisieux A. Combaret V, et al. Among authors: noguera r. J Clin Oncol. 2005 Dec 1;23(34):8919-20; author reply 8920. doi: 10.1200/JCO.2005.04.0170. J Clin Oncol. 2005. PMID: 16314658 No abstract available.
Molecular biology of neuroblastoma.
Castel V, Grau E, Noguera R, Martínez F. Castel V, et al. Among authors: noguera r. Clin Transl Oncol. 2007 Aug;9(8):478-83. doi: 10.1007/s12094-007-0091-7. Clin Transl Oncol. 2007. PMID: 17720650 Review.
Influence of neuroblastoma stage on serum-based detection of MYCN amplification.
Combaret V, Hogarty MD, London WB, McGrady P, Iacono I, Brejon S, Swerts K, Noguera R, Gross N, Rousseau R, Puisieux A. Combaret V, et al. Among authors: noguera r. Pediatr Blood Cancer. 2009 Sep;53(3):329-31. doi: 10.1002/pbc.22009. Pediatr Blood Cancer. 2009. PMID: 19301388 Free PMC article.
Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study.
Vermeulen J, De Preter K, Naranjo A, Vercruysse L, Van Roy N, Hellemans J, Swerts K, Bravo S, Scaruffi P, Tonini GP, De Bernardi B, Noguera R, Piqueras M, Cañete A, Castel V, Janoueix-Lerosey I, Delattre O, Schleiermacher G, Michon J, Combaret V, Fischer M, Oberthuer A, Ambros PF, Beiske K, Bénard J, Marques B, Rubie H, Kohler J, Pötschger U, Ladenstein R, Hogarty MD, McGrady P, London WB, Laureys G, Speleman F, Vandesompele J. Vermeulen J, et al. Among authors: noguera r. Lancet Oncol. 2009 Jul;10(7):663-71. doi: 10.1016/S1470-2045(09)70154-8. Epub 2009 Jun 8. Lancet Oncol. 2009. PMID: 19515614 Free PMC article.
MYCN/c-MYC-induced microRNAs repress coding gene networks associated with poor outcome in MYCN/c-MYC-activated tumors.
Mestdagh P, Fredlund E, Pattyn F, Schulte JH, Muth D, Vermeulen J, Kumps C, Schlierf S, De Preter K, Van Roy N, Noguera R, Laureys G, Schramm A, Eggert A, Westermann F, Speleman F, Vandesompele J. Mestdagh P, et al. Among authors: noguera r. Oncogene. 2010 Mar 4;29(9):1394-404. doi: 10.1038/onc.2009.429. Epub 2009 Nov 30. Oncogene. 2010. PMID: 19946337
179 results